Please ensure Javascript is enabled for purposes of website accessibility
Search
Accessibility Menu
TransMedics Group Stock Quote

TransMedics Group (NASDAQ: TMDX)

$134.83
(-1.0%)
-$1.31
Price as of May 16, 2024, 3:21 p.m. ET

TransMedics Group Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
TMDX +81.86% +359.78% +35.68% +509%
S&P +29.16% +85.63% +13.17% +82%

TransMedics Group Company Info

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.